240 related articles for article (PubMed ID: 22495502)
1. Arthralgia during aromatase inhibitor treatment in early breast cancer patients: prevalence, impact, and recognition by healthcare providers.
Boonstra A; van Zadelhoff J; Timmer-Bonte A; Ottevanger PB; Beurskens CH; van Laarhoven HW
Cancer Nurs; 2013; 36(1):52-9. PubMed ID: 22495502
[TBL] [Abstract][Full Text] [Related]
2. Aromatase inhibitor-associated arthralgia syndrome.
Burstein HJ
Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
[TBL] [Abstract][Full Text] [Related]
3. Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations.
Coleman RE; Bolten WW; Lansdown M; Dale S; Jackisch C; Merkel D; Maass N; Hadji P
Cancer Treat Rev; 2008 May; 34(3):275-82. PubMed ID: 18082328
[TBL] [Abstract][Full Text] [Related]
4. Identification of tools to measure changes in musculoskeletal symptoms and physical functioning in women with breast cancer receiving aromatase inhibitors.
Swenson KK; Nissen MJ; Henly SJ; Maybon L; Pupkes J; Zwicky K; Tsai ML; Shapiro AC
Oncol Nurs Forum; 2013 Nov; 40(6):549-57. PubMed ID: 24161633
[TBL] [Abstract][Full Text] [Related]
5. Tai chi for well-being of breast cancer survivors with aromatase inhibitor-associated arthralgias: a feasibility study.
Galantino ML; Callens ML; Cardena GJ; Piela NL; Mao JJ
Altern Ther Health Med; 2013; 19(6):38-44. PubMed ID: 24254037
[TBL] [Abstract][Full Text] [Related]
6. A qualitative exploration of the impact of yoga on breast cancer survivors with aromatase inhibitor-associated arthralgias.
Galantino ML; Greene L; Archetto B; Baumgartner M; Hassall P; Murphy JK; Umstetter J; Desai K
Explore (NY); 2012; 8(1):40-7. PubMed ID: 22225932
[TBL] [Abstract][Full Text] [Related]
7. Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome.
Morales L; Pans S; Verschueren K; Van Calster B; Paridaens R; Westhovens R; Timmerman D; De Smet L; Vergote I; Christiaens MR; Neven P
J Clin Oncol; 2008 Jul; 26(19):3147-52. PubMed ID: 18474874
[TBL] [Abstract][Full Text] [Related]
8. New views on treatment of aromatase inhibitors induced arthralgia.
Xepapadakis G; Ntasiou P; Koronarchis D; Koufoudakis D; Panousis D; Grosomanidis D; Venizelos V; Georgiadis S
Breast; 2010 Jun; 19(3):249-50. PubMed ID: 20418100
[TBL] [Abstract][Full Text] [Related]
9. Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia.
Dizdar O; Ozçakar L; Malas FU; Harputluoglu H; Bulut N; Aksoy S; Ozisik Y; Altundag K
J Clin Oncol; 2009 Oct; 27(30):4955-60. PubMed ID: 19752344
[TBL] [Abstract][Full Text] [Related]
10. Acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer: pilot study.
Oh B; Kimble B; Costa DS; Davis E; McLean A; Orme K; Beith J
Acupunct Med; 2013 Sep; 31(3):264-71. PubMed ID: 23722951
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.
Crew KD; Greenlee H; Capodice J; Raptis G; Brafman L; Fuentes D; Sierra A; Hershman DL
J Clin Oncol; 2007 Sep; 25(25):3877-83. PubMed ID: 17761973
[TBL] [Abstract][Full Text] [Related]
12. Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.
Brier MJ; Chambless DL; Chen J; Mao JJ
Eur J Cancer; 2018 Mar; 91():145-152. PubMed ID: 29329697
[TBL] [Abstract][Full Text] [Related]
13. Aromatase inhibitor-associated arthralgia and/ or bone pain: frequency and characterization in non-clinical trial patients.
Presant CA; Bosserman L; Young T; Vakil M; Horns R; Upadhyaya G; Ebrahimi B; Yeon C; Howard F
Clin Breast Cancer; 2007 Oct; 7(10):775-8. PubMed ID: 18021478
[TBL] [Abstract][Full Text] [Related]
14. Short-term and low-dose prednisolone administration reduces aromatase inhibitor-induced arthralgia in patients with breast cancer.
Kubo M; Onishi H; Kuroki S; Okido M; Shimada K; Yokohata K; Umeda S; Ogawa T; Tanaka M; Katano M
Anticancer Res; 2012 Jun; 32(6):2331-6. PubMed ID: 22641670
[TBL] [Abstract][Full Text] [Related]
15. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors.
Irwin ML; Cartmel B; Gross CP; Ercolano E; Li F; Yao X; Fiellin M; Capozza S; Rothbard M; Zhou Y; Harrigan M; Sanft T; Schmitz K; Neogi T; Hershman D; Ligibel J
J Clin Oncol; 2015 Apr; 33(10):1104-11. PubMed ID: 25452437
[TBL] [Abstract][Full Text] [Related]
16. Randomized Controlled Trial of a Home-Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors.
Nyrop KA; Callahan LF; Cleveland RJ; Arbeeva LL; Hackney BS; Muss HB
Oncologist; 2017 Oct; 22(10):1238-1249. PubMed ID: 28698390
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of arthralgia with estrogen deprivation.
Lintermans A; Neven P
Steroids; 2011 Jul; 76(8):781-5. PubMed ID: 21377484
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of aromatase inhibitor associated arthralgia: known and potential candidate genes and associated biomarkers.
Borrie AE; Kim RB
Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):149-156. PubMed ID: 27635473
[TBL] [Abstract][Full Text] [Related]
19. Classification of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective multicenter cohort study.
Laroche F; Coste J; Medkour T; Cottu PH; Pierga JY; Lotz JP; Beerblock K; Tournigand C; Declèves X; de Cremoux P; Bouhassira D; Perrot S
J Pain; 2014 Mar; 15(3):293-303. PubMed ID: 24365325
[TBL] [Abstract][Full Text] [Related]
20. Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we find out more?
Din OS; Dodwell D; Wakefield RJ; Coleman RE
Breast Cancer Res Treat; 2010 Apr; 120(3):525-38. PubMed ID: 20157776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
